Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Ischemia reperfusion.php on line 2
Ischemia reperfusion
LE WE PMID CA
Ischemia reperfusion1381Ischaemie Reperfusion

Adenosine

AM251 ttCB1

AM404

AMP activated protein kinase

Apoptosis

Arginine

Autophagy

BIRC5 Survivin

Blood vessels (Permeability)

BNIP3

Calcitonin gene related peptide

Calcium (sarcoplasmic reticulum)

Calsequestrin

Capsaicin

Ceramide

CGRP8 37 ttCGRP

CNS (Astrocyte)

CNS (Stroke BASKET)

Connexin43

delta 9 tetraydrocannabinol

Edaravone

Endocannabinoid

Endothelial dysfunction

Endovanilloid

Epilepsy (Excitotoxicity)

Epoxyeicosatrienoic acid EET

ERS UFR (Diseases)

ERS UFR (Induced Mediators)

ERS UFR (Pharmacology)

Ethylpyruvate

GADD153 CHOP

Gap junction

GSK3

H89 ttPKA

Heart (Arrhythmia)

Heart (Coronary heart disease BASKET)

Heart (Ventricular fibrillation)

Hedgehog

Heme oxygenase

HIF1alpha und HIF1 (BASKET)

Hypoxia (tissue local)

Interleukin6

Ischemia reperfusion

Ischemic preconditioning

Junctin

JWH133

Liver (Anatomy)

MANF Mesencephalic astrocyte derived neurotrophic factor

Melatonin

Mitochondria (BASKET)

Mitochondria (Dysfunction)

Mitochondria (Permeability transition)

MTOR

N oleoyldopamine

Neuroprotective agents

Neutrophils

Nitric oxide NO

Nitrite

Nitrosative stress

PAR2

PKC epsilon V1 2 ttPKCepsilon

Proteasome (BASKET)

Protein (ptm Tyrosine nitration)

Protein phosphatase1 inhibitor1

PUMA

Receptor (Cannabinoid)

Receptor (Ryanodine)

Redox (BASKET)

RP67580 ttNeurokinin1

Sarcoplasmic reticulum

SHC

Shock

SLIGRL ttPAR2

Sphingolipids

Sphingosine kinase

Sphingosine1 phosphate

STAT3

Substance P

Superoxide dismutase SOD

SXBP1

Tetrabutylammonium tt PotassiumChannels

TGF beta

TLR2

TLR4

Transplantation

Transporter (Sodium and calcium)

Triadin

TRPV1

TRPV4

Ubiquitin

2001  
1
Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury.
[11465607] Anesthesiology 94(6): 1133-8 (2001)
2006  
2
The pathophysiology of myocardial reperfusion: a pathologist's perspective.
[16547203] Heart 92(11): 1559-62 (2006)
2006  
3
The role of oxidants and free radicals in reperfusion injury.
[16580655] Cardiovasc Res 70(2): 181-90 (2006)
2006  
4
Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole.
[16497286] Cardiovasc Res 70(2): 191-9 (2006)
2004  
5
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
[14962479] Cardiovasc Res 61(3): 481-97 (2004)
2004  
6
Poly(ADP-ribose) polymerase activation in the reperfused myocardium.
[14962478] Cardiovasc Res 61(3): 471-80 (2004)
2004  
7
Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection.
[14962470] Cardiovasc Res 61(3): 372-85 (2004)
1999  
8
The role of neutrophils in myocardial ischemia-reperfusion injury.
[10615413] Cardiovasc Res 43(4): 860-78 (1999)
2004  
9
Emerging roles of proteasomes in ischemia-reperfusion injury of organs.
[15082863] J Physiol Pharmacol 55(1 Pt 1): 3-15 (2004)
1998  
10
Mechanisms of cell death in hypoxia/reoxygenation injury.
[9916996] Oncogene 17(25): 3341-9 (1998)
2008  
11
Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.
[18391174] Physiol Rev 88(2): 581-609 (2008)
2008  
12
Molecular physiology of preconditioning-induced brain tolerance to ischemia.
[18195087] Physiol Rev 88(1): 211-47 (2008)
2003  
13
Preconditioning the myocardium: from cellular physiology to clinical cardiology.
[14506302] Physiol Rev 83(4): 1113-51 (2003)
1999  
14
Molecular and cellular mechanisms of myocardial stunning.
[10221990] Physiol Rev 79(2): 609-34 (1999)
2008  
15
Molecular mediators of liver ischemia and reperfusion injury: a brief review.
[18292799] Mol Med 14(5-6): 337-45 (2008)
2001  
16
The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection.
[11474130] Mol Med 7(6): 367-82 (2001)
2003  
17
Complement in ischemia reperfusion injury.
[12547694] Am J Pathol 162(2): 363-7 (2003)
2007  
18
Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion.
[16971498] Am J Physiol Cell Physiol 292(1): C137-47 (2007)
2005  
19
Myocardial postconditioning: reperfusion injury revisited.
[15961374] Am J Physiol Heart Circ Physiol 289(1): H2-7 (2005)
2006  
20
Nitrite therapy for protection against ischemia-reperfusion injury.
[16527923] Am J Physiol Renal Physiol 290(4): F777-8 (2006)
2003  
21
Ischemia-reperfusion-induced lung injury.
[12588712] Am J Respir Crit Care Med 167(4): 490-511 (2003)
2007  
22
The roles of autophagy in cerebral ischemia.
[17035724] Autophagy 3(1): 42-4 (2007)
2009  
23
Gap junctions mediate the spread of ischemia-reperfusion injury.
[19706984] Circ J 73(9): 1591-2 (2009)
2005  
24
Pulmonary ischaemia-reperfusion injury: role of apoptosis.
[15684303] Eur Respir J 25(2): 356-63 (2005)
1992  
25
Oxygen free radicals and cardiac reperfusion abnormalities.
[1618547] Hypertension 20(1): 118-27 (1992)
2008  
26
Mitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: mitochondrial targeted preconditioning.
[18652858] Adv Drug Deliv Rev 60(13-14): 1471-7 (2008)
2002  
27
Mechanisms of ischemic preconditioning and its application in transplantation.
[12465427] Ann Transplant 7(3): 12-20 (2002)
2004  
28
Heme oxygenase system in ischemia and reperfusion injury.
[15478901] Ann Transplant 9(1): 84-7 (2004)
2003  
29
Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning.
[12488232] Am J Physiol Gastrointest Liver Physiol 284(1): G15-26 (2003)
2006  
30
Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions.
[16687579] Am J Physiol Gastrointest Liver Physiol 290(6): G1083-8 (2006)
2010  
31
Nitroglycerin-induced preconditioning: interaction with nitrate tolerance.
[20008266] Am J Physiol Heart Circ Physiol 298(2): H308-9 (2010)
2007  
32
Cerebrovascular effects of ischemic preconditioning: endothelial survivin joins the fray.
[17400725] Am J Physiol Heart Circ Physiol 292(6): H2559-60 (2007)
2009  
33
Clinical cardioprotection and the value of conditioning responses.
[19363132] Am J Physiol Heart Circ Physiol 296(6): H1705-20 (2009)
2007  
34
The role of mitochondria in protection of the heart by preconditioning.
[17631856] Biochim Biophys Acta 1767(8): 1007-31 (2007)
2008  
35
Sphingolipid therapy in myocardial ischemia-reperfusion injury.
[17928150] Biochim Biophys Acta 1780(3): 571-6 (2008)
2005  
36
The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review.
[16123965] Liver Transpl 11(9): 1031-47 (2005)
2008  
37
Ischemic preconditioning of the liver: a few perspectives from the bench to bedside translation.
[18975290] Liver Transpl 14(11): 1569-77 (2008)
2008  
38
The reperfusion syndrome: have we made any progress?
[18383086] Liver Transpl 14(4): 412-4 (2008)
2002  
39
Fundamentals of reperfusion injury for the clinical cardiologist.
[12021216] Circulation 105(20): 2332-6 (2002)
2009  
40
Clinical application of remote ischemic preconditioning.
[19221230] Circulation 119(6): 776-8 (2009)
2011  
41
Remote ischemic preconditioning. -Is it time to introduce it in clinical practice?-.
[21727750] Circ J 75(8): 1821-2 (2011)
2002  
42
Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion.
[11744010] Cardiovasc Res 53(1): 12-30 (2002)
2002  
43
Triggers and promoters of ischaemic preconditioning.
[12237159] Cardiovasc Res 56(1): 1-3 (2002)
2010  
44
Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure.
[20299333] Cardiovasc Res 87(2): 291-9 (2010)
2010  
45
Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis.
[20562423] Cardiovasc Res 88(1): 7-15 (2010)
2004  
46
Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis.
[15094352] Cardiovasc Res 62(2): 323-34 (2004)
2004  
47
Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion.
[14962471] Cardiovasc Res 61(3): 386-401 (2004)
2004  
48
Nitric oxide in myocardial ischemia/reperfusion injury.
[14962472] Cardiovasc Res 61(3): 402-13 (2004)
2004  
49
Role of apoptosis in reperfusion injury.
[14962473] Cardiovasc Res 61(3): 414-26 (2004)
2004  
50
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.
[14962476] Cardiovasc Res 61(3): 448-60 (2004)
2004  
51
New concepts in reactive oxygen species and cardiovascular reperfusion physiology.
[14962477] Cardiovasc Res 61(3): 461-70 (2004)
2004  
52
The first minutes of reperfusion: a window of opportunity for cardioprotection.
[14962469] Cardiovasc Res 61(3): 365-71 (2004)
2010  
53
Proteasome inhibition during myocardial infarction.
[19744947] Cardiovasc Res 85(2): 312-20 (2010)
2010  
54
The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.
[19793765] Cardiovasc Res 85(2): 303-11 (2010)
2007  
55
Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics.
[17568573] Cardiovasc Res 75(2): 327-38 (2007)
2007  
56
Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
[17306241] Cardiovasc Res 74(3): 343-55 (2007)
2007  
57
Mechanism of action and delivery possibilities for TGFbeta1 in the treatment of myocardial ischemia.
[17331484] Cardiovasc Res 74(2): 235-43 (2007)
2009  
58
Orphan targets for reperfusion injury.
[19351740] Cardiovasc Res 83(2): 169-78 (2009)
2009  
59
The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage.
[19351741] Cardiovasc Res 83(2): 262-8 (2009)
2009  
60
Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues.
[19502282] Cardiovasc Res 83(2): 165-8 (2009)
2009  
61
The tail of Cx43: its crucial protective role in acute myocardial infarction.
[19812045] Cardiovasc Res 84(3): 337-8 (2009)
2008  
62
Sarcoplasmic reticulum-mitochondrial interaction in the mechanism of acute reperfusion injury. Viewpoint.
[18006433] Cardiovasc Res 77(2): 234-6 (2008)
2008  
63
Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion.
[18259200] Cell Death Differ 15(4): 686-90 (2008)
2011  
64
Neuroprotection caused by hyperoxia preconditioning in animal stroke models.
[21336456] ScientificWorldJournal 11(-): 403-21 (2011)
2003  
65
Mitochondria: role in ischemia, reperfusion and cell death.
[12769003] Rev Port Cardiol 22(2): 233-54 (2003)
2006  
66
Signaling pathways involved in the cardioprotective effects of cannabinoids.
[17031075] J Pharmacol Sci 102(2): 155-66 (2006)
2004  
67
Forefront of Na+/Ca2+ exchanger studies: role of Na+/Ca2+ exchanger--lessons from knockout mice.
[15359083] J Pharmacol Sci 96(1): 23-6 (2004)
2009  
68
Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in myocardial protection against ischemia/reperfusion injury.
[19179805] J Pharmacol Sci 109(2): 162-7 (2009)
2003  
69
Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning.
[12598407] Br J Pharmacol 138(4): 532-43 (2003)
2009  
70
Role of nitroso radicals as drug targets in circulatory shock.
[19630831] Br J Pharmacol 157(4): 494-508 (2009)
2008  
71
Autophagic neuron death in neonatal brain ischemia/hypoxia.
[18212531] Autophagy 4(4): 404-8 (2008)
2009  
72
Mitochondria and vascular pathology.
[19307700] Pharmacol Rep 61(1): 123-30 (2009)
2007  
73
Ischemic preconditioning: protection against myocardial necrosis and apoptosis.
[18078014] Vasc Health Risk Manag 3(5): 629-37 (2007)
2009  
74
Translational cardiovascular medicine (II). Pathophysiology of ischemia-reperfusion injury: new therapeutic options for acute myocardial infarction.
[19232193] Rev Esp Cardiol 62(2): 199-209 (2009)
2010  
75
TLR2 and TLR4 in ischemia reperfusion injury.
[20628516] Mediators Inflamm 2010(-): 704202 (2010)
2004  
76
A unique pathway of cardiac myocyte death caused by hypoxia-acidosis.
[15299040] J Exp Biol 207(Pt 18): 3189-200 (2004)
2010  
77
The Hedgehog morphogen in myocardial ischemia-reperfusion injury.
[20407076] Exp Biol Med (Maywood) 235(4): 447-54 (2010)
2009  
78
Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury.
[18940177] Arch Biochem Biophys 484(2): 232-7 (2009)
2009  
79
Cardioprotection by metabolic shut-down and gradual wake-up.
[19285082] J Mol Cell Cardiol 46(6): 804-10 (2009)
2011  
80
C/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation.
[21330607] Arterioscler Thromb Vasc Biol 31(5): 1124-32 (2011)
2012  
81
Ablation of junctin or triadin is associated with increased cardiac injury following ischaemia/reperfusion.
[22411973] Cardiovasc Res 94(2): 333-41 (2012)
2007  
82
PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress.
[17107669] Cardiovasc Res 73(1): 48-56 (2007)
2009  
83
Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury.
[19299645] Circ Res 104(8): 1012-20 (2009)
2012  
84
Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury: possible mechanisms.
[22455352] Clin Sci (Lond) 123(2): 93-8 (2012)
2010  
85
Widespread cortical expression of MANF by AAV serotype 7: localization and protection against ischemic brain injury.
[20685313] Exp Neurol 225(1): 104-13 (2010)
2009  
86
Reduced L-arginine transport contributes to the pathogenesis of myocardial ischemia-reperfusion injury.
[19544385] J Cell Biochem 108(1): 156-68 (2009)
2008  
87
N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1.
[18567714] Am J Physiol Heart Circ Physiol 295(2): H728-35 (2008)
2007  
88
TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice.
[17586621] Am J Physiol Heart Circ Physiol 293(3): H1791-8 (2007)
2009  
89
Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
[19812353] Am J Physiol Regul Integr Comp Physiol 297(6): R1681-90 (2009)
2007  
90
Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors.
[17965746] Br J Pharmacol 152(8): 1301-11 (2007)
2012  
91
TRPV1 agonist capsaicin attenuates lung ischemia-reperfusion injury in rabbits.
[20950828] J Surg Res 173(1): 153-60 (2012)
2010  
92
Impact of epoxyeicosatrienoic acids in lung ischemia-reperfusion injury.
[20163540] Microcirculation 17(2): 137-46 (2010)
2012  
93
The increased activity of TRPV4 channel in the astrocytes of the adult rat hippocampus after cerebral hypoxia/ischemia.
[22761937] PLoS One 7(6): e39959 (2012)
2010  
94
Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection.
[20157789] Mol Neurobiol 41(2-3): 172-9 (2010)
2009  
95
Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.
[19835566] Curr Med Chem 16(33): 4382-98 (2009)
2011  
96
Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species.
[21772945] World J Cardiol 3(6): 186-200 (2011)
2010  
97
Ischemia/reperfusion injury: The role of immune cells.
[21160610] World J Cardiol 2(10): 325-32 (2010)
2012  
98
Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury.
[21822424] Exp Diabetes Res 2012(-): 198048 (2012)
2009  
99
Ceramide and mitochondria in ischemia/reperfusion.
[19247196] J Cardiovasc Pharmacol 53(3): 198-208 (2009)
2009  
100
Sphingosine kinase and sphingosine 1-phosphate in cardioprotection.
[19247197] J Cardiovasc Pharmacol 53(3): 189-97 (2009)
2004  
101
Molecular signaling pathways in ischemia/reperfusion.
[15859924] Exp Clin Transplant 2(1): 174-7 (2004)
2009  
102
Inflammatory mediators of liver ischemia-reperfusion injury.
[19715511] Exp Clin Transplant 7(2): 78-93 (2009)
2010  
103
Leukocytes and the inflammatory response in ischemia-reperfusion injury.
[21340389] Rev Bras Cir Cardiovasc 25(4): 575-84 (2010)
2009  
104
The mitochondrial permeability transition pore and ischemia-reperfusion injury.
[19242640] Basic Res Cardiol 104(2): 181-8 (2009)
2009  
105
Adenosine receptors and reperfusion injury of the heart.
[19639283] Handb Exp Pharmacol -(193): 189-214 (2009)
2008  
106
Factors in the pathophysiology of the liver ischemia-reperfusion injury.
[17707862] J Surg Res 147(1): 153-9 (2008)
2011  
107
Divergent roles of superoxide and nitric oxide in liver ischemia and reperfusion injury.
[21297912] J Clin Biochem Nutr 48(1): 50-6 (2011)
2003  
108
Pathogenesis and protection of ischemia and reperfusion injury in myocardium.
[14578938] J Nihon Med Sch 70(5): 384-92 (2003)
2007  
109
Ischemia-reperfusion and immediate T cell responses.
[17942086] Cell Immunol 248(1): 4-11 (2007)
2007  
110
Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury.
[17164132] Prostaglandins Other Lipid Mediat 82(1-4): 50-9 (2007)
2011  
111
Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury.
[21559063] Front Physiol 2(-): 13 (2011)
2004  
112
Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance.
[15638116] Gen Physiol Biophys 23(3): 265-95 (2004)
2010  
113
Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.
[21182223] World J Gastroenterol 16(48): 6087-97 (2010)
2010  
114
Role of nitric oxide in hepatic ischemia-reperfusion injury.
[21182222] World J Gastroenterol 16(48): 6079-86 (2010)
2010  
115
Hepatic organ protection: from basic science to clinical practice.
[21182218] World J Gastroenterol 16(48): 6044-5 (2010)
PMC   
116
Ethyl pyruvate ameliorates hepatic ischemia-reperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy.
[24453420] Mediators Inflamm 2013():461536 (2013)
PMC   
117
CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism.
[23204107] Circulation 127(1):63-73 (2013)
PMC   
118
Effect of dexmedetomidine on lung ischemiareperfusion injury.
[24345905] Mol Med Rep 9(2):419-26 (2014)
PMC   
119
An emerging need for developing new models for myocardial infarction as a chronic complex disease: lessons learnt from animal vs. human studies on cardioprotective effects of Erythropoietin in reperfused myocardium.
[24575050] Front Physiol 5():44 (2014)
PMC   
120
Tyrosine nitration of voltage-dependent anion channels in cardiac ischemia-reperfusion: reduction by peroxynitrite scavenging.
[22709907] Biochim Biophys Acta 1817(11):2049-59 (2012)
PMC   
121
Histone deacetylase signaling in cardioprotection.
[24310814] Cell Mol Life Sci 71(9):1673-90 (2014)
PMC   
122
Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery.
[24719539] J Saudi Heart Assoc 26(2):93-100 (2014)
PMC   
123
A device for performing automated balloon catheter inflation ischemia studies.
[24769885] PLoS One 9(4):e95823 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Ischemia reperfusion.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Ischemia reperfusion.php on line 92